VBI Vaccines
Signal active
Organization
Contact Information
Overview
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus.
VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.
About
Industries
Biotechnology, Health Care, Clinical Trials
Founded
2001
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
VBI Vaccines headquartered in United States, North America, operates in the Biotechnology, Health Care, Clinical Trials sector. The company focuses on Biotechnology and has secured $161.1B in funding across 300 round(s). With a team of 101-250 employees, VBI Vaccines is actively contributing to advancements in Biotechnology. Their latest funding round, Debt Financing - VBI Vaccines, raised $2.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
25
Investors
0
Lead Investors
0
Total Funding Amount
$537.0M
Details
1
VBI Vaccines has raised a total of $537.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2007 | Early Stage Venture | 35.7M |
Investors
VBI Vaccines is funded by 34 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Perceptive Advisors | - | FUNDING ROUND - Perceptive Advisors | 13.6M |
| Steven Gillis | - | FUNDING ROUND - Steven Gillis | 13.6M |
| VBI Vaccines | - | FUNDING ROUND - VBI Vaccines | 13.6M |
| ARCH Venture Partners | - | FUNDING ROUND - ARCH Venture Partners | 13.6M |
Recent Activity
There is no recent news or activity for this profile.